Research results
Emory received $734 million in external research funding in fiscal year 2018, the most ever for the university.
Emory received $734 million in external research funding in fiscal year 2018, the most ever for the university.
“At Emory, striving for excellence means staying engaged with the challenges facing our world,” says President Claire E. Sterk. “It means bringing together the most brilliant and creative minds to collaborate in ways that only we can, serving as an incubator for research and a driver for compassionate innovation.”
Emory’s external research funding for this year represents a 17 percent increase from $628 million in fiscal year 2017. During the past ten years, research funding has increased by nearly 52 percent.
“This significant increase, following a rising trajectory over the past decade, reflects the dedication and expertise of our faculty,” says Deborah W. Bruner, senior vice president for research. “Emory is increasingly recognized as one of the nation’s leading research institutions, due to advances by our scientists fueled by a passion for discovery and collaboration.”
Emory is increasingly recognized as one of the nation’s leading research institutions, due to advances by our scientists fueled by a passion for discovery and collaboration.
For the first time, the Child Health and Mortality Prevention Surveillance Network (CHAMPS) is making available cause-of-death data from children under the age of five in South Asia and Sub-Saharan Africa, where infant and childhood mortality are exceptionally high.
Since 2015, CHAMPS, with the Emory Global Health Institute as lead partner, has been focused on preventing childhood mortality in developing countries with support from the Bill & Melinda Gates Foundation. Through an initial $75 million from the Gates Foundation, CHAMPS has partnered with governments and national public health institutes on a long-term approach to information management, laboratory infrastructure, and workforce capacity. CHAMPS recently was granted an additional $25 million by the Gates Foundation.
As the CHAMPS network gathers and shares specific cause-of-death data, researchers and child health programs will be able to use it to develop effective interventions.
Closer to home, after a decade of collaboration among Atlanta partners Emory, Morehouse School of Medicine, and Georgia Tech, the Atlanta Clinical and Translational Science Institute expanded to include the University of Georgia and received a new name: the Georgia Clinical and Translational Science Alliance (Georgia CTSA).
In the process, the Emory-led alliance received a new five-year, $51 million CTSA award from the National Institutes of Health. The Georgia CTSA is part of a national network of more than fifty academic medical centers across the country working to ensure innovative and effective treatments are available to more patients by improving the translational research process.
And the National Science Foundation awarded another $20 million to Emory’s Center for Selective C-H Functionalization to fund the next phase of a global effort to revolutionize the field of organic synthesis.
“Our center is at the forefront of a major shift in the way that we do chemistry,” says Huw Davies, professor of chemistry at Emory and the director of the Center for Selective C-H Functionalization. “This shift holds great promise for creating new pathways for drug discovery and the production of new materials, to benefit everything from agriculture to electronics.”
Add Fuel to the Fire: Gifts to Emory College of Arts and Sciences support research projects that lead to brighter futures. Engage!
